GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amrutanjan Health Care Ltd (NSE:AMRUTANJAN) » Definitions » Cyclically Adjusted Revenue per Share

Amrutanjan Health Care (NSE:AMRUTANJAN) Cyclically Adjusted Revenue per Share : ₹118.25 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Amrutanjan Health Care Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Amrutanjan Health Care's adjusted revenue per share data for the fiscal year that ended in Mar. 2024 was ₹145.177. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹118.25 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Amrutanjan Health Care's average Cyclically Adjusted Revenue Growth Rate was 10.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 10.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 11.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Amrutanjan Health Care was 11.40% per year. The lowest was 9.20% per year. And the median was 10.95% per year.

As of today (2024-06-09), Amrutanjan Health Care's current stock price is ₹ 725.20. Amrutanjan Health Care's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Mar. 2024 was ₹118.25. Amrutanjan Health Care's Cyclically Adjusted PS Ratio of today is 6.13.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Amrutanjan Health Care was 9.39. The lowest was 3.97. And the median was 5.62.


Amrutanjan Health Care Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Amrutanjan Health Care's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amrutanjan Health Care Cyclically Adjusted Revenue per Share Chart

Amrutanjan Health Care Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 77.49 86.69 96.60 107.21 118.25

Amrutanjan Health Care Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 107.21 - - - 118.25

Competitive Comparison of Amrutanjan Health Care's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Amrutanjan Health Care's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amrutanjan Health Care's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amrutanjan Health Care's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Amrutanjan Health Care's Cyclically Adjusted PS Ratio falls into.



Amrutanjan Health Care Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Amrutanjan Health Care's adjusted Revenue per Share data for the fiscal year that ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=145.177/153.0345*153.0345
=145.177

Current CPI (Mar. 2024) = 153.0345.

Amrutanjan Health Care Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201503 56.984 97.163 89.752
201603 63.076 102.518 94.157
201703 71.357 105.196 103.807
201803 74.868 109.786 104.361
201903 86.199 118.202 111.601
202003 89.192 124.705 109.454
202103 113.737 131.771 132.091
202203 139.106 138.822 153.348
202303 129.897 146.865 135.354
202403 145.177 153.035 145.177

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Amrutanjan Health Care  (NSE:AMRUTANJAN) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Amrutanjan Health Care's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=725.20/118.25
=6.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Amrutanjan Health Care was 9.39. The lowest was 3.97. And the median was 5.62.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Amrutanjan Health Care Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Amrutanjan Health Care's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Amrutanjan Health Care (NSE:AMRUTANJAN) Business Description

Traded in Other Exchanges
Address
No. 103 (Old No. 42-45), Luz Church Road, Mylapore, Chennai, TN, IND, 600 004
Amrutanjan Health Care Ltd manufactures Ayurvedic and allopathic products. The company operates through the following segments: OTC Products, Beverages, and Others. The majority of the revenue is generated from its OTC segment which is engaged in the manufacturing products of pain management, congestion management, and hygiene. Its beverage segment includes manufacturing fruit juices and oral rehydration drinks. Some of its products include Roll-on, Spray, Balm, Cough Syrup, Sanitary napkin, and inhaler. Geographically, it generates the majority of the revenue from India.

Amrutanjan Health Care (NSE:AMRUTANJAN) Headlines

No Headlines